IMNN
Imunon, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.34
−2.90%0
Insider buys (3m)
6
Insider sells (3m)
-$38.2K
Net value (3m)
-21.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 15, 2026 | Tardugno Michael H · director, officer: Executive Chairman of Board | A-Award | 5,824 | $1.47 |
| Sep 15, 2026 | Faller Douglas Vincent · officer: Chief Medical Officer | A-Award | 4,211 | $1.47 |
| Sep 15, 2026 | Lindborg Stacy · director, officer: President and CEO | A-Award | 5,504 | $1.47 |
| Sep 1, 2026 | Faller Douglas Vincent · officer: Chief Medical Officer | A-Award | 3,626 | $1.60 |
| Sep 1, 2026 | Tardugno Michael H · director, officer: Executive Chairman of Board | A-Award | 7,371 | $1.60 |
| Sep 1, 2026 | Lindborg Stacy · director, officer: President and CEO | A-Award | 6,822 | $1.60 |
| Sep 1, 2026 | Eylward Susan · officer: General Counsel and Corp Sec | Sale | 2,525 | $1.56 |
| Sep 1, 2026 | Eylward Susan · officer: General Counsel and Corp Sec | A-Award | 2,525 | $1.60 |
| Aug 17, 2026 | Tardugno Michael H · director, officer: Executive Chairman of Board | A-Award | 7,147 | $1.65 |
| Aug 17, 2026 | Eylward Susan · officer: General Counsel and Corp Sec | Sale | 2,449 | $1.63 |
| Aug 17, 2026 | Faller Douglas Vincent · officer: Chief Medical Officer | A-Award | 3,516 | $1.65 |
| Aug 17, 2026 | Eylward Susan · officer: General Counsel and Corp Sec | A-Award | 2,449 | $1.65 |
| Aug 17, 2026 | Lindborg Stacy · director, officer: President and CEO | A-Award | 6,615 | $1.65 |
| Aug 4, 2026 | Tardugno Michael H · director, officer: Executive Chairman of Board | A-Award | 6,358 | $1.59 |
| Aug 4, 2026 | Eylward Susan · officer: General Counsel and Corp Sec | A-Award | 2,541 | $1.59 |
| Aug 4, 2026 | Dentzer James E · director | A-Award | 6,934 | $1.59 |
| Aug 4, 2026 | Lindborg Stacy · director, officer: President and CEO | A-Award | 5,010 | $1.59 |
| Aug 4, 2026 | Braun Donald P · director | A-Award | 6,180 | $1.59 |
| Aug 4, 2026 | Faller Douglas Vincent · officer: Chief Medical Officer | A-Award | 3,649 | $1.59 |
| Aug 4, 2026 | Eylward Susan · officer: General Counsel and Corp Sec | Sale | 2,541 | $1.57 |
| Aug 4, 2026 | Pellizzari Christine A · director | A-Award | 6,934 | $1.59 |
| Aug 4, 2026 | Fritz Frederick J. · director | A-Award | 6,934 | $1.59 |
| Jul 21, 2026 | Lindborg Stacy · director, officer: President and CEO | A-Award | 4,907 | $1.83 |
| Jul 21, 2026 | Tardugno Michael H · director, officer: Executive Chairman of Board | A-Award | 4,603 | $1.83 |
| Jul 21, 2026 | Eylward Susan · officer: General Counsel and Corp Sec | A-Award | 2,150 | $1.83 |
| Jul 21, 2026 | Eylward Susan · officer: General Counsel and Corp Sec | Sale | 2,150 | $1.78 |
| Jul 21, 2026 | Faller Douglas Vincent · officer: Chief Medical Officer | A-Award | 3,082 | $1.83 |
| Jul 7, 2026 | Faller Douglas Vincent · officer: Chief Medical Officer | A-Award | 1,308 | $1.91 |
| Jul 7, 2026 | Eylward Susan · officer: General Counsel and Corp Sec | Sale | 920 | $1.88 |
| Jul 7, 2026 | Eylward Susan · officer: General Counsel and Corp Sec | A-Award | 920 | $1.91 |
Institutional positioning
13F filings over the trailing two quarters
New 9Increased 7Reduced 8Sold out 2
| Filer | Action | Shares | Filed |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | Increased | 348,330 | May 15, 2026 |
| ARMISTICE CAPITAL, LLC | Reduced | 144,767 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 48,056 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 46,967 | Aug 13, 2026 |
| RIVERVIEW CAPITAL ADVISERS, LLC | Unchanged | 34,364 | May 14, 2026 |
| Riverview Capital Advisers, LLC | Unchanged | 34,364 | Aug 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 33,211 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 31,629 | Aug 12, 2026 |
| Virtu Financial LLC | New Position | 17,456 | Aug 13, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 13,269 | May 8, 2026 |
| VANGUARD FIDUCIARY TRUST CO | Unchanged | 13,269 | Aug 13, 2026 |
| HRT FINANCIAL LP | New Position | 12,055 | May 14, 2026 |
| NORTHERN TRUST CORP | New Position | 10,342 | Aug 13, 2026 |
| UBS Group AG | Increased | 5,203 | Aug 13, 2026 |
| BLACKROCK, INC. | Unchanged | 4,464 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 15, 2026